{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:01:30Z","timestamp":1763535690380,"version":"3.37.3"},"reference-count":40,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["U1171"],"award-info":[{"award-number":["U1171"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec><jats:title>Background and objective<\/jats:title><jats:p>Predictors of symptomatic haemorrhagic transformation (s-HT) of cerebral ischaemia after intravenous recombinant tissue-plasminogen activator (rt-PA) were identified in studies using CT scans. We evaluated whether MRI can identify other predictors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>We analysed predictors of s-HT in a cohort of consecutive patients who received intravenous rt-PA for cerebral ischaemia after MRI at baseline. We used receiver operating characteristic curves considering an area under the curve (AUC) of 0.70 or higher as indicating acceptable discrimination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 944 patients, 49 patients (5.2%) developed s-HT. Clinical factors independently associated with s-HT were age (adjusted OR (adjOR) 1.03 for 1\u2009year increase; 95% CI 1.01 to 1.05), excessive alcohol consumption (adjOR 3.13; 95%\u2009CI 1.32 to 7.42), recent transient ischaemic attack (adjOR 2.88; 95%\u2009CI 1.04 to 7.95) and baseline national institutes of health stroke scale score (adjOR 1.06 for 1 point increase; 95%\u2009CI 1.02 to 1.10). MRI predictors were vascular hyperintensities (adjOR 3.89; 95%\u2009CI 1.50 to 10.08), old infarcts (adjOR 2.01; 95%\u2009CI 1.11 to 3.66) and volume of diffusion-weighted imaging (DWI) abnormality (adjOR 1.02 for 1\u2009cm<jats:sup>3<\/jats:sup> increase; 95%\u2009CI 1.01 to 1.03). The only variable with an acceptable discrimination was volume of DWI abnormality (AUC 0.72; 95%\u2009CI 0.64 to 0.79), a value of 4\u2009cm<jats:sup>3<\/jats:sup> predicting s-HT with a 78% sensitivity and 58% specificity. Variables that can be assessed only with MRI did not predict s-HT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although the volume of DWI abnormality predicts s-HT, other imaging characteristics that can only be assessed with MRI were not significantly associated with s-HT.<\/jats:p><jats:p><jats:bold>Trial\nregistration number<\/jats:bold><\/jats:p><jats:p>NCT01614080<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2019-321904","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T22:15:25Z","timestamp":1580768125000},"page":"402-410","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Use of MRI to predict symptomatic haemorrhagic transformation after thrombolysis for cerebral ischaemia"],"prefix":"10.1136","volume":"91","clinical-trial-number":[{"clinical-trial-number":"nct01614080","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Fran\u00e7ois","family":"Caparros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Kuchcinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agathe","family":"Drelon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Casolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solene","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelly","family":"Dequatre-Ponchelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Henon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Pruvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4408-4392","authenticated-orcid":false,"given":"Didier","family":"Leys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"key":"key-10.1136\/jnnp-2019-321904-1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-2","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2019-321904-3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2019-321904-4","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"key-10.1136\/jnnp-2019-321904-5","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","article-title":"The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy","volume":"46","author":"von Kummer","year":"2015","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS)","volume":"274","author":"Hacke","year":"1995","journal-title":"JAMA"},{"key":"key-10.1136\/jnnp-2019-321904-7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)","volume":"352","author":"Hacke","year":"1998","journal-title":"The Lancet"},{"key":"key-10.1136\/jnnp-2019-321904-8","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The atlantis study: a randomized controlled trial. alteplase thrombolysis for acute Noninterventional therapy in ischemic stroke","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"key-10.1136\/jnnp-2019-321904-9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1474-4422(08)70044-9","article-title":"Effects of alteplase beyond 3 H after stroke in the Echoplanar imaging thrombolytic evaluation trial (epithet): a placebo-controlled randomised trial","volume":"7","author":"Davis","year":"2008","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2019-321904-10","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial","volume":"379","author":"Sandercock","year":"2012","journal-title":"Lancet"},{"key":"key-10.1136\/jnnp-2019-321904-11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","article-title":"Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in Stroke-Monitoring study (SITS-MOST): an observational study","volume":"369","author":"Wahlgren","year":"2007","journal-title":"Lancet"},{"key":"key-10.1136\/jnnp-2019-321904-12","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/STROKEAHA.110.589606","article-title":"Thrombolysis with 0.6 mg\/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-marketing alteplase registration study (J-MARS)","volume":"41","author":"Nakagawara","year":"2010","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1503\/cmaj.1041561","article-title":"Thrombolysis for acute ischemic stroke: results of the Canadian alteplase for stroke effectiveness study","volume":"172","author":"Hill","year":"2005","journal-title":"Can Med Assoc J"},{"key":"key-10.1136\/jnnp-2019-321904-14","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/brain\/awl387","article-title":"Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting","volume":"130","author":"Cordonnier","year":"2007","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2019-321904-15","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1212\/WNL.0000000000004665","article-title":"Cortical superficial siderosis multifocality in cerebral amyloid angiopathy","volume":"89","author":"Charidimou","year":"2017","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2019-321904-16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/WNL.55.2.265","article-title":"Significance of hyperintense vessels on FLAIR MRI in acute stroke","volume":"55","author":"Kamran","year":"2000","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2019-321904-17","first-page":"1050","article-title":"Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusion-weighted imaging and early parenchymal enhancement","volume":"26","author":"Kim","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"key-10.1136\/jnnp-2019-321904-18","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1148\/rg.325115760","article-title":"Sequence-Specific MR imaging findings that are useful in dating ischemic stroke","volume":"32","author":"Allen","year":"2012","journal-title":"RadioGraphics"},{"key":"key-10.1136\/jnnp-2019-321904-19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000007921","article-title":"White matter changes on CT and MRI: an overview of visual rating scales. European Task force on age-related white matter changes","volume":"39","author":"Scheltens","year":"1998","journal-title":"Eur Neurol"},{"key":"key-10.1136\/jnnp-2019-321904-20","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/STROKEAHA.115.009290","article-title":"Microbleed status and 3-month outcome after intravenous thrombolysis in 717 patients with acute ischemic stroke","volume":"46","author":"Turc","year":"2015","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neurol.2017.03.023","article-title":"Are the results of intravenous thrombolysis trials reproduced in clinical practice? comparison of observed and expected outcomes with the Stroke-Thrombolytic predictive instrument (STPI)","volume":"173","author":"Decourcelle","year":"2017","journal-title":"Rev Neurol"},{"key":"key-10.1136\/jnnp-2019-321904-22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000131083","article-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","volume":"25","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"key-10.1136\/jnnp-2019-321904-23","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/01.STR.25.11.2220","article-title":"Improved reliability of the NIH stroke scale using video training. NINDS TPA stroke Study Group","volume":"25","author":"Lyden","year":"1994","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. definitions for use in a multicenter clinical trial. TOAST. trial of ORG 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-25","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1161\/01.STR.0000022808.21776.BF","article-title":"Assessment of functioning and disability after ischemic stroke","volume":"33","author":"Weimar","year":"2002","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000262309","article-title":"Comparison of telephone and face-to-face assessment of the modified Rankin scale","volume":"29","author":"Janssen","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"key-10.1136\/jnnp-2019-321904-27","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(12)70203-X","article-title":"Mri profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study","volume":"11","author":"Lansberg","year":"2012","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2019-321904-28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/STROKEAHA.116.014343","article-title":"Multiparametric magnetic resonance imaging for prediction of parenchymal hemorrhage in acute ischemic stroke after reperfusion therapy","volume":"48","author":"Nael","year":"2017","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"Mr signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"key-10.1136\/jnnp-2019-321904-30","first-page":"46","article-title":"Comparison of Stopping Rules in Forward \u201cStepwise\u201d Regression","volume":"72","author":"Bendel","year":"1977","journal-title":"J Am Stat Assoc"},{"volume-title":"Primer of applied regression and analysis of variance","year":"1990","author":"Glantz","key":"key-10.1136\/jnnp-2019-321904-31"},{"key":"key-10.1136\/jnnp-2019-321904-32","first-page":"160","volume-title":"Applied logistic regression","author":"Hosmer","year":"1989","edition":"2"},{"key":"key-10.1136\/jnnp-2019-321904-33","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.STR.32.5.1079","article-title":"Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke","volume":"32","author":"Molina","year":"2001","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-34","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/STROKEAHA.109.550111","article-title":"Risk assessment of symptomatic intracerebral hemorrhage after thrombolysis using DWI-ASPECTS","volume":"40","author":"Singer","year":"2009","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-35","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/STROKEAHA.112.665331","article-title":"Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies","volume":"43","author":"Whiteley","year":"2012","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000439184","article-title":"Cortical superficial siderosis and risk of bleeding after thrombolysis for ischemic stroke","volume":"40","author":"Gattringer","year":"2015","journal-title":"Cerebrovasc Dis"},{"key":"key-10.1136\/jnnp-2019-321904-37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/STROKEAHA.118.023689","article-title":"Hemorrhagic transformation after thrombectomy for tandem occlusions","volume":"50","author":"Zhu","year":"2019","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2019-321904-38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00234-016-1775-x","article-title":"Severe cerebral hypovolemia on perfusion CT and lower body weight are associated with parenchymal haemorrhage after thrombolysis","volume":"59","author":"Tsetsou","year":"2017","journal-title":"Neuroradiology"},{"key":"key-10.1136\/jnnp-2019-321904-39","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1177\/0271678X17718099","article-title":"Cerebral hyperperfusion on arterial spin labeling MRI after reperfusion therapy is related to hemorrhagic transformation","volume":"37","author":"Okazaki","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"key-10.1136\/jnnp-2019-321904-40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000083180","article-title":"Reperfusion after severe local perfusion deficit precedes hemorrhagic transformation: an MRI study in acute stroke patients","volume":"19","author":"Fiehler","year":"2005","journal-title":"Cerebrovasc Dis"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2019-321904","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:50:49Z","timestamp":1601095849000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2019-321904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,3,16]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1136\/jnnp-2019-321904"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2019-321904","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"type":"print","value":"0022-3050"},{"type":"electronic","value":"1468-330X"}],"subject":[],"published":{"date-parts":[[2020,2,3]]}}}